| 期 |
标题 |
文件 |
| 卷 31, 编号 31 (2024) |
Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment? |
(Eng)
|
|
Hao S., Cai D., Gou S., Li Y., Liu L., Tang X., Chen Y., Zhao Y., Shen J., Wu X., Li M., Chen M., Li X., Sun Y., Gu L., Li W., Wang F., Cho C., Xiao Z., Du F.
|
| 卷 31, 编号 39 (2024) |
Does Eta Protein Differentiate Rheumatoid Arthritis from Psoriatic Arthritis? |
(Eng)
|
|
Kor A., Orhan K., Maraş Y., Oğuz E., Unan M., Dilek G., Erten Ş., Nas K.
|
| 卷 31, 编号 22 (2024) |
Does Laterality in Breast Cancer still have the Importance to be Studied? A Meta-analysis of Patients with Breast Cancer |
(Eng)
|
|
Zheng X., Xu C., Ganesan K., Chen H., Cheung Y., Chen J.
|
| 卷 31, 编号 4 (2024) |
Does Quinoa (Chenopodium quinoa) Consumption Improve Blood Glucose, Body Weight and Body Mass Index? A Systematic Review and Dose-Response Meta-Analysis of Clinical Trials |
(Eng)
|
|
Atefi M., Heidari Z., Shojaei M., Askari G., Kesharwani P., Bagherniya M., Sahebkar A.
|
| 卷 31, 编号 23 (2024) |
Drug Delivery Systems based on Microneedles for Dermatological Diseases and Aesthetic Enhancement |
(Eng)
|
|
Vergilio M., Birchall J., Lima L., Rezende R., Leonardi G.
|
| 卷 31, 编号 16 (2024) |
Drug Discovery Efforts to Identify Novel Treatments for Neglected Tropical Diseases - Cysteine Protease Inhibitors |
(Eng)
|
|
Giroud M., Kuhn B., Haap W.
|
| 卷 31, 编号 38 (2024) |
Drug Repurposing against Novel Therapeutic Targets in Plasmodium falciparum for Malaria: The Computational Perspective |
(Eng)
|
|
Rai S., Shukla S., Scotti L., Mani A.
|
| 卷 31, 编号 14 (2024) |
Drugs to Treat Neuroinflammation in Neurodegenerative Disorders |
(Eng)
|
|
Wang Y., Kung W., Chung Y., Kumar S.
|
| 卷 31, 编号 13 (2024) |
Early-Life Lead Exposure: Risks and Neurotoxic Consequences |
(Eng)
|
|
Bjørklund G., Tippairote T., Hangan T., Chirumbolo S., Peana M.
|
| 卷 31, 编号 3 (2024) |
Effectiveness In Vivo and In Vitro of Polymeric Nanoparticles as a Drug Release System in the Treatment of Leishmaniasis |
(Eng)
|
|
de Carvalho Moreira L., de Sousa Silva A., de Araújo Medeiros K., Oshiro Júnior J., da Silva D., de Lima Damasceno B.
|
| 卷 31, 编号 40 (2024) |
Effects of Consuming Repeatedly Heated Edible Oils on Cardiovascular Diseases: A Narrative Review |
(Eng)
|
|
Soundararajan P., Parthasarathy S., Sakthivelu M., Karuppiah K., Velusamy P., Gopinath S., Raman P.
|
| 卷 31, 编号 23 (2024) |
Effects of Dietary Flavonoids on the Metabolism of Vortioxetine and its Potential Mechanism |
(Eng)
|
|
Lin Y., Wang Y., Ye Z., Gao N., Xu X., Weng Q., Xu R., Ye L.
|
| 卷 31, 编号 20 (2024) |
Effects of Trehalose Administration in Patients with Mucopolysaccharidosis Type III |
(Eng)
|
|
Mobini M., Radbakhsh S., Kubaski F., Eshraghi P., Vakili S., Vakili R., Abbasifard M., Jamialahmadi T., Rajabi O., Emami S., Tayarani-Najaran Z., Rizzo M., Eid A., Banach M., Sahebkar A.
|
| 卷 31, 编号 2 (2024) |
Efficacy and Safety of Alirocumab and Evolocumab as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis |
(Eng)
|
|
Ghasempour G., Zamani-Garmsiri F., Shaikhnia F., Soleimani A., Hosseini Fard S., Leila J., Teimuri S., Parvaz N., Mohammadi P., Najafi M.
|
| 卷 31, 编号 18 (2024) |
Efficacy of Chemoimmunotherapy versus Chemotherapy for Gastric Cancer: A Meta-Analysis of Survival Outcomes |
(Eng)
|
|
Xie J., Chen L., Liu Q., Li X., Lei X.
|
| 卷 31, 编号 21 (2024) |
Efficacy of the Novel Formulation of Topical Liothyronine and Liothyronine-insulin in Mild to Moderate Diabetic Foot Ulcer: A Randomized, Triple-blind Clinical Trial |
(Eng)
|
|
Saghafi F., Khalilzadeh S., Ramezani V., Pasandeh F., Fallahzadeh H., Sahebnasagh A.
|
| 卷 31, 编号 25 (2024) |
Electrochemical Label-free Methods for Ultrasensitive Multiplex Protein Profiling of Infectious Diseases |
(Eng)
|
|
Madhurantakam S., Churcher N., Kumar R., Prasad S.
|
| 卷 31, 编号 19 (2024) |
Emodin Alcohols: Design, Synthesis, Biological Evaluation and Multitargeting Studies with DNA, RNA, and HSA |
(Eng)
|
|
Wang H., Zhang H.
|
| 卷 31, 编号 8 (2024) |
Enlightening the Mechanism of Ferroptosis in Epileptic Heart |
(Eng)
|
|
Akyüz E., Saleem Q., Sari Ç., Auzmendi J., Lazarowski A.
|
| 卷 31, 编号 17 (2024) |
Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review |
(Eng)
|
|
Yenkoyan K., Mkhitaryan M., Bjørklund G.
|
| 卷 31, 编号 35 (2024) |
EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections |
(Eng)
|
|
Vincenzi M., Mercurio F., Leone M.
|
| 卷 31, 编号 23 (2024) |
Essential Trace Elements in Patients with Dyslipidemia: A Meta-analysis |
(Eng)
|
|
Li C., Song Y., Lin Z., Ma M., He L.
|
| 卷 31, 编号 2 (2024) |
Estrogen Receptor and the Gender Bias in Raynauds Phenomenon |
(Eng)
|
|
Fardoun M., Kobeissy F., Eid A.
|
| 卷 31, 编号 40 (2024) |
Evaluation of Treatments with Radiotherapy Alone and Radiotherapy Plus Chemo-immunotherapy in Patients with Primary Liver Cancer based on Blood Biomarkers |
(Eng)
|
|
Huang S., Yin Y., Li J., Shi M., Bian H., Zhao L.
|
| 卷 31, 编号 41 (2024) |
Evidence from Machine Learning, Diagnostic Hub Genes in Sepsis and Diagnostic Models based on Xgboost Models, Novel Molecular Models for the Diagnosis of Sepsis |
(Eng)
|
|
Yu Y., Li J., Li J., Zen X., Fu Q.
|
| 卷 31, 编号 37 (2024) |
Exosomal Non-coding RNAs: A New Approach to Melanoma Diagnosis and Therapeutic Strategy |
(Eng)
|
|
Liu J., Hu X., Xin W., Wang X.
|
| 卷 31, 编号 17 (2024) |
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery |
(Eng)
|
|
Bitencourt-Ferreira G., Villarreal M., Quiroga R., Biziukova N., Poroikov V., Tarasova O., de Azevedo Junior W.
|
| 卷 31, 编号 37 (2024) |
Exploring the Role of Nitric Oxide in Lower Airway Diseases: Insights and Real-world Application |
(Eng)
|
|
Ambrosino P., Marcuccio G., Maniscalco M.
|
| 卷 31, 编号 25 (2024) |
Expression of Circulating miR-21 and -29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy |
(Eng)
|
|
Tousoulis D., Tsioufis K., Vlachopoulos C., Angelopoulos A., Oikonomou E., Antonopoulos A., Theofilis P., Zisimos K., Katsarou O., Gazouli M., Lazaros G., Papanikolaou P., Siasos G.
|
| 卷 31, 编号 31 (2024) |
Ferroptosis-induced Cardiotoxicity and Antitumor Drugs |
(Eng)
|
|
Beretta G.
|
| 卷 31, 编号 3 (2024) |
First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation |
(Eng)
|
|
De S.
|
| 卷 31, 编号 7 (2024) |
First Approval of Elacestrant as a Selective Estrogen Receptor Degrader for the Treatment of Metastatic Breast Cancer |
(Eng)
|
|
De S.
|
| 卷 31, 编号 40 (2024) |
Fluvastatin: A Choice for COVID-19-associated Mucormycosis Management |
(Eng)
|
|
Tavakkoli A., Johnston T., Sahebkar A.
|
| 卷 31, 编号 38 (2024) |
Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor |
(Eng)
|
|
Jiang Y., Wu Y., Wang J., Ma Y., Yu H., Wang Z.
|
| 卷 31, 编号 41 (2024) |
From Plants to Therapies: Exploring the Pharmacology of Coumestrol for Neurological Conditions |
(Eng)
|
|
Singla M., Verma S., Thakur K., Goyal A., Sharma V., Sharma D., Porwal O., Subramaniyan V., Behl T., Singh S., Dua K., Gupta G., Gupta S.
|
| 卷 31, 编号 6 (2024) |
Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct Cancer |
(Eng)
|
|
De S.
|
| 卷 31, 编号 4 (2024) |
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder |
(Eng)
|
|
De S.
|
| 卷 31, 编号 5 (2024) |
Generation of Autoantibodies in Metal-catalyzed Oxidatively Damaged DNA in Various Cancer Subjects |
(Eng)
|
|
Ahmad S., Alshammari Q., Rafi Z., Rehman S., Khan M., Faisal M., Alatar A.
|
| 卷 31, 编号 28 (2024) |
Georgian Medicinal Plants as Rich Natural Sources of Antioxidant Derivatives: A Review on the Current Knowledge and Future Perspectives |
(Eng)
|
|
Pirtskhalava M., Mittova V., Tsetskhladze Z., Palumbo R., Pastore R., Roviello G.
|
| 卷 31, 编号 15 (2024) |
Ginsenoside Rg1 Suppresses Ferroptosis of Renal Tubular Epithelial Cells in Sepsis-induced Acute Kidney Injury via the FSP1-CoQ10- NAD(P)H Pathway |
(Eng)
|
|
Guo J., Chen L., Ma M.
|
| 卷 31, 编号 36 (2024) |
Graph Neural Networks with Multi-features for Predicting Cocrystals using APIs and Coformers Interactions |
(Eng)
|
|
Mswahili M., Jo K., Lee S., Jeong Y.
|
| 卷 31, 编号 4 (2024) |
Herbal Substances with Antiviral Effects: Features and Prospects for the Treatment of Viral Diseases with Emphasis on Pro-Inflammatory Cytokines |
(Eng)
|
|
Bjørklund G., Lysiuk R., Semenova Y., Lenchyk L., Dub N., Doşa M., Hangan T.
|
| 卷 31, 编号 12 (2024) |
Heterogeneity of Lipid Metabolism and its Clinical and Immune Correlation in Lung Adenocarcinoma |
(Eng)
|
|
Zhang X., Li W., Liu T., Guo H., Sun Q., Li B.
|
| 卷 31, 编号 22 (2024) |
High-expression of FABP4 in Tubules is a Risk Factor for Poor Prognosis in DKD Patients |
(Eng)
|
|
Huang Y., Cui X., Li Z., Yuan S., Han Y., Xu X., Fu X., Shi K., Zhang Z., Wei J., Xia S., Xiao Y., Xue S., Sun L., Liu H., Zhu X.
|
| 卷 31, 编号 17 (2024) |
High-Resolution Profiling of Head and Neck Squamous Cells Carcinoma Identifies Specific Biomarkers and Expression Subtypes of Clinically Relevant Vulnerabilities |
(Eng)
|
|
Zhu Y., Peng B., Luo X., Sun W., Liu D., Li N., Qiu P., Long G.
|
| 卷 31, 编号 14 (2024) |
High-sensitivity Troponin (hs-Tn) for Cardiovascular Risk Prognostication: A Systematic Review and Meta-analysis |
(Eng)
|
|
Sagris M., Antonopoulos A., Angelopoulos A., Papanikolaou P., Simantiris S., Vamvakaris C., Koumpoura A., Farmaki M., Antoniades C., Tsioufis C., Tousoulis D.
|
| 卷 31, 编号 27 (2024) |
How Important is the Metal-free Catalytic Knoevenagel Reaction in Medicinal Chemistry? An Updated Review |
(Eng)
|
|
Johari S., Johan M., Khaligh N.
|
| 卷 31, 编号 33 (2024) |
Human Umbilical Cord Mesenchymal Stem Cell Exosome-derived miR-335-5p Alleviated Lipopolysaccharide-induced Acute Lung Injury by Regulating the m6A Level of ITGβ4 Gene |
(Eng)
|
|
Li L., Zhang X., Chen Y.
|
| 卷 31, 编号 19 (2024) |
Hybrids Diazine: Recent Advancements in Modern Antimicrobial Therapy |
(Eng)
|
|
Mangalagiu V., Danac R., Diaconu D., Zbancioc G., Mangalagiu I.
|
| 卷 31, 编号 21 (2024) |
Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19 |
(Eng)
|
|
Abolfazli S., Ebrahimi N., Morabi E., Asgari Yazdi M., Zengin G., Sathyapalan T., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 13 (2024) |
Identification of a Novel Diagnosis Model based on 5 Hub Genes for Chronic Thromboembolic Pulmonary Hypertension |
(Eng)
|
|
Zhang F., Huang X., Lin J., Yu R., Lin S., Shen G., Chen W.
|
| 卷 31, 编号 28 (2024) |
Identification of an Exosome-relevant SNHG6-hsa-miR-429- CHRDL1/CCNA2 Axis for Lung Adenocarcinoma Prognosis Evaluation |
(Eng)
|
|
Yuan Y., Li Q., Chen F., Zhao Y., Ma J., Fang S.
|
| 卷 31, 编号 39 (2024) |
Identification of Crosstalk Genes between Lung Adenocarcinoma and Periodontitis |
(Eng)
|
|
Wang P., Yu H., Gao X., Guo Z., Zhang Z., Wang Z.
|
| 卷 31, 编号 12 (2024) |
Identification of Key Genes in Angiogenesis of Breast and Prostate Cancers in the Context of Different Cell Types |
(Eng)
|
|
Jariani A., Kakroodi S., Arabfard M., Jamialahmadi T., Rahimi M., Sahebkar A.
|
| 卷 31, 编号 33 (2024) |
Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme |
(Eng)
|
|
Li Z., Jin Y., Que T., Zhang X., Yi G., Zheng H., Yuan X., Wang X., Xu H., Nan J., Chen C., Wu Y., Huang G.
|
| 卷 31, 编号 12 (2024) |
Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction |
(Eng)
|
|
Li N., Yu K., Huang D., Zhou H., Zeng D.
|
| 卷 31, 编号 42 (2024) |
Identifying Hub Genes for Glaucoma based on Bulk RNA Sequencing Data and Multi-machine Learning Models |
(Eng)
|
|
Xie Y., Yu K.
|
| 卷 31, 编号 33 (2024) |
Identifying Luteolin as a Potential Drug for Treating Lung Adenocarcinoma with COVID-19 Affection based on Integration Analysis of Pharmacology and Transcriptome |
(Eng)
|
|
Peng P., Li N., Zhang N., Fu X., Peng S., Zhao Y., Ai B.
|
| 卷 31, 编号 5 (2024) |
Imidazo[4,5-b]Pyridines: From Kinase Inhibitors to more Diversified Biological Properties |
(Eng)
|
|
Jarmoni K., Misbahi K., Ferrières V.
|
| 卷 31, 编号 14 (2024) |
Impact of Statin or Fibrate Therapy on Homocysteine Concentrations: A Systematic Review and Meta-analysis |
(Eng)
|
|
Akbari A., Islampanah M., Arhaminiya H., Alvandi Fard M., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 26 (2024) |
In Silico Immunogenicity Assessment of Therapeutic Peptides |
(Eng)
|
|
Li W., Wei J., Jiang Q., Zhou Y., Yan X., Xiang C., Huang J.
|
| 卷 31, 编号 37 (2024) |
In Silico Screening and Molecular Dynamics Simulations against Tyrosine-protein Kinase Fyn Reveal Potential Novel Therapeutic Candidates for Bovine Papillomatosis |
(Eng)
|
|
Barros G., Barreto D., Cavalcanti S., Oliveira T., Rodrigues R., de Aragão Batista M.
|
| 卷 31, 编号 7 (2024) |
In silico Studies on Natural Products and Derivatives against Different Types of Cancer |
(Eng)
|
|
Messias Monteiro A., da Silva F., Rodrigues T., Ramos C., Scotti M., Scotti L.
|
| 卷 31, 编号 13 (2024) |
Inflammatory Response Modulation by Low-Dose Anti-inflammatory Drugs Treatment in an In Vitro Osteoarthritis Cellular Model |
(Eng)
|
|
Iuliano M., Santilli V., Mineo A., Paoloni M., Rosa P., Mangino G., Romeo G.
|
| 卷 31, 编号 5 (2024) |
Integrated High-throughput Transcriptomic Data Identifies Survivin as a Potential Breast Cancer Therapeutic Biomarker |
(Eng)
|
|
Mirza Z.
|
| 卷 31, 编号 42 (2024) |
Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma |
(Eng)
|
|
Du Y., Jiang X., Zhang Y., Ying J., Yi Q.
|
| 卷 31, 编号 23 (2024) |
Involvement of Nrf2 Signaling in Lead-induced Toxicity |
(Eng)
|
|
Arabnezhad M., Haghani F., Ghaffarian-Bahraman A., Jafarzadeh E., Mohammadi H., Yadegari J., Farkhondeh T., Aschner M., Darroudi M., Marouzi S., Samarghandian S.
|
| 卷 31, 编号 27 (2024) |
Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders |
(Eng)
|
|
Semenova Y., Bjørklund G., Butnariu M., Peana M.
|
| 卷 31, 编号 42 (2024) |
Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis? |
(Eng)
|
|
Orekhov A., Sukhorukov V., Melnichenko A.
|
| 卷 31, 编号 28 (2024) |
Kidney Injury: Focus on Molecular Signaling Pathways |
(Eng)
|
|
Liu W., Hu M., Wang L., Mirzaei H.
|
| 卷 31, 编号 25 (2024) |
Leukemia Inhibitory Factor Protects against Degeneration of Cone Photoreceptors Caused by RPE65 Deficiency |
(Eng)
|
|
Dong S., Zhen F., Zou T., Zhou Y., Wu J., Wang T., Zhang H.
|
| 卷 31, 编号 17 (2024) |
LIMD2 is the Signature of Cell Aging-immune/Inflammation in Acute Myocardial Infarction |
(Eng)
|
|
Tao P., Chen X., Xu L., Chen J., Nie Q., Xu M., Feng J.
|
| 卷 31, 编号 24 (2024) |
LINC00891 Promotes Tumorigenesis and Metastasis of Thyroid Cancer by Regulating SMAD2/3 via EZH2 |
(Eng)
|
|
Si Y., Wen J., Hu C., Chen H., Lin L., Xu Y., Ren D., Meng X., Wang Y., Xia E., Bhandari A., Wang O.
|
| 卷 31, 编号 31 (2024) |
Linoleic and Arachidonic Fatty Acids and their Potential Relationship with Inflammation, Pregnancy, and Fetal Development |
(Eng)
|
|
Ortiz M., Álvarez D., Muñoz Y., Crisosto N., Valenzuela R., Maliqueo M.
|
| 卷 31, 编号 37 (2024) |
LncRNA MEG3: Targeting the Molecular Mechanisms and Pathogenic causes of Metabolic Diseases |
(Eng)
|
|
Luo Y., Wang H., Wang L., Wu W., Zhao J., Li X., Xiong R., Ding X., Yuan D., Yuan C.
|
| 卷 31, 编号 6 (2024) |
LncRNA PVT1 as a Novel Biomarker for Diabetes-related Complications |
(Eng)
|
|
Qiu X., Chen J., Yang J., Hu J., Fan P., Yuan C.
|
| 卷 31, 编号 10 (2024) |
LncRNA-mediated Modulation of Endothelial Cells: Novel Progress in the Pathogenesis of Coronary Atherosclerotic Disease |
(Eng)
|
|
Ouyang S., Zhou Z., Liu H., Ren Z., Liu H., Deng N., Tian K., Zhou K., Xie H., Jiang Z.
|
| 卷 31, 编号 1 (2024) |
Long COVID-19 Syndrome and Sudden Cardiac Death: The Phantom Menace |
(Eng)
|
|
Spartalis M., Zweiker D., Spartalis E., Iliopoulos D., Siasos G.
|
| 卷 31, 编号 29 (2024) |
Long Non-coding RNA DNM3OS: Pathogenic Roles and Molecular Mechanisms in Pathophysiological Processes |
(Eng)
|
|
Wang S., Hu Y., Wang R., Zhang Y., Yuan Q., Yuan C.
|
| 卷 31, 编号 41 (2024) |
Marine Bacteria: A Source of Novel Bioactive Natural Products |
(Eng)
|
|
Zha X., Ji R., Zhou S.
|
| 卷 31, 编号 24 (2024) |
Mass Spectrometry-based Detection of Mycotoxins in Imported Meat and their Perspective Role on Myocardial Apoptosis |
(Eng)
|
|
Ansari M., Al Abbasi F., Hosawi S., Baig M., Alhayyani S., Kumar V., Asar T., Anwar F.
|
| 卷 31, 编号 35 (2024) |
Mechanisms of the Quorum Sensing Systems of Pseudomonas aeruginosa: Host and Bacteria |
(Eng)
|
|
Flores-Percino D., Osorio-Llanes E., Sepulveda Y., Castellar- López J., Madera R., Rada W., Meléndez C., Mendoza-Torres E.
|
| 卷 31, 编号 34 (2024) |
Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview |
(Eng)
|
|
Khator R., Biharee A., Bhatia N., Kulkarni S., Singh Y., Karthikeyan C., Jain A., Thareja S.
|
| 卷 31, 编号 34 (2024) |
Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future |
(Eng)
|
|
Pijeira M., Nunes P., Chaviano S., Diaz A., DaSilva J., Ricci-Junior E., Alencar L., Chen X., Santos-Oliveira R.
|
| 卷 31, 编号 8 (2024) |
Meet the Country Editor |
(Eng)
|
|
Marazziti D.
|
| 卷 31, 编号 10 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Heymann D.
|
| 卷 31, 编号 11 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Iqbal J.
|
| 卷 31, 编号 12 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Cichero E.
|
| 卷 31, 编号 13 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Beretta G.
|
| 卷 31, 编号 2 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Benbrook D.
|
| 卷 31, 编号 3 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Bertho G.
|
| 卷 31, 编号 4 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Amoroso R.
|
| 卷 31, 编号 6 (2024) |
Meet the Regional Editor |
(Eng)
|
|
Chen C.
|
| 卷 31, 编号 9 (2024) |
Meet the Regional Editor |
(Eng)
|
|
Campos J.
|
| 卷 31, 编号 11 (2024) |
Melatonin as a Promising Agent for Cancer Treatment: Insights into its Effects on the Wnt/beta-catenin Signaling Pathway |
(Eng)
|
|
Davoodvandi A., Asemi R., Sharifi M., Reiter R., Matini S., Mirhashemi S., Asemi Z.
|
| 卷 31, 编号 24 (2024) |
Meta-analysis of the Impact of Bariatric Surgery on Circulating TMAO Levels as a Predictor of Cardiovascular Disease Risk |
(Eng)
|
|
Jamialahmadi T., Simental-Mendia L., Zengin G., Almahmeed W., Kesharwani P., Sahebkar A.
|
| 卷 31, 编号 9 (2024) |
Metabolic Reprogramming of Immune Cells Following Vaccination: From Metabolites to Personalized Vaccinology |
(Eng)
|
|
Mussap M., Puddu M., Fanos V.
|
| 卷 31, 编号 13 (2024) |
Metabolome Profiling of Malignant Ascites Identifies Candidate Metabolic Biomarkers of Hepatocellular Carcinoma |
(Eng)
|
|
Wang W., Wu Y., Zhang Q., Cui P.
|
| 卷 31, 编号 23 (2024) |
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis |
(Eng)
|
|
Mahmoudi A., Butler A., De Vincentis A., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 41 (2024) |
MicroRNA Profiles in Critically Ill Patients |
(Eng)
|
|
Alikiaii B., Bagherniya M., Askari G., Rajendram R., Sahebkar A.
|
| 101 - 200 的 400 信息 |
<< < 1 2 3 4 > >> |
